Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
Status:
Recruiting
Trial end date:
2022-02-22
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the pharmacokinetics, systemic exposure, safety
and tolerability after daily topical application of SKX-16 (Luliconazole 10% Solution) for
duration of 29 days in a maximal use setting in adults with moderate to severe distal
subungual onychomycosis of the toenails.